ArticleIrish journal of medical science2023

PLK4 inhibitor plus bortezomib exhibits a synergistic effect on treating multiple myeloma via inactivating PI3K/AKT signaling.

Biao Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.